Genetic and genomic screening
One Stop diagnostics
Advanced and innovative oncology as standard
Our centres are equipped with the latest-generation linear accelerators and new modalities as standard.
Oncology treatment is rapidly evolving, with new modalities offering reduced acute and long-term impacts along with significantly improved life outcomes for curative and palliative patients. GenesisCare is at the forefront of the introduction of innovative and advanced radiotherapy techniques.
Delivers a highly precise and personalised dose to the target area while minimising dose to adjacent organs. Significantly improves treatment outcomes for many tumour types, including breast, prostate, head and neck, and palliative treatments.
Delivers targeted beams of high-dose radiation and is revolutionising the treatment of lung, liver, bone, nodal, prostate, brain, head and neck cancers. We’re using these technologies to design new accelerated treatment plans that significantly reduce overall acute and long-term toxicity of treatment.
One of the first healthcare provider in the UK to introduce this revolutionary new modality that allows real-time adaptive planning and on-treatment organ motion monitoring and gating of tumours, such as prostate.
The latest 3D and 4D set-up techniques monitor movement to ensure accurate targeting, reduced time on the bed and tattoo-free treatment.
We have introduced Deep Inspiration Breath Hold (DIBH) to reduce radiation to the lungs and heart in breast cancer patients.
At GenesisCare we offer spacers at no extra cost to patients who haven’t had their prostate removed and who are undergoing VMAT radiotherapy for prostate cancer. Spacers reduce the radiation exposure to the rectum during prostate cancer radiotherapy meaning fewer side effects and better quality of life.
Used in all centres using 3D Cone Beam verification to provide a precise internal picture of the treatment site. We are also using the MRIdian to establish an magnetic resonance image guided radiotherapy (MRIgRT) service.
We are the leading independent provider of neuro-oncology in the UK. We offer an end-to-end solution that involves eloquent brain area-sparing technologies and innovative protocols, delivered through a team of leading clinicians at our centre in Oxford.
We’re pioneering the use of Theranostics, an innovative step towards personalised medicine. This combines PET/CT imaging and radiopharmaceuticals to diagnose and treat metastatic disease.
We provide a full range of systemic anti-cancer therapies in our private, individual chemotherapy suites. This includes:
- iQemo management platform
- Nurses on call 24/7
- Acute pathways
- Dedicated resident medical officer on site to ensure patient safety
Partner with us
We are always looking to collaborate with talented consultants.
As an oncologist, surgeon or related cancer specialist, we invite you to partner with us. We welcome requests from individuals and academic institutions to access our state-of-the-art equipment and clinical support for treatment and research. You can also build your knowledge and network with peers at our many CPD events.
Please email REM@genesiscare.co.uk for further information about partnering with us.
What exceptional care looks like
Designing and delivering better ways to improve life outcomes for our patients
As part of a successful global company, we have access to world-class expertise and work together with teams of cancer specialists to design and deliver better ways to improve life outcomes for our patients. As a patient, that means a complete care plan tailored around you. Our goal is to deliver exceptional treatment and care in a way that enhances every aspect your patient’s cancer journey.
Patients ready for radical treatment within five days of scanning and within two days for palliative patients. Same-day scanning, planning and treatment on request.
We believe care should be focused on an individual, not just their cancer. That means:
- Convenient locations, with transport and accommodation provided for radiotherapy patients
- One-to-one cancer nurse specialists
- Highly skilled treatment radiographers
- Triage and acute admissions
- Personalised exercise medicine
Patient safety is at the heart of what we do. We are CQC inspected and have a comprehensive governance framework that ensures safe treatment protocols, evaluates consultant practising privileges and reviews cases outside standard treatment protocols. Research and knowledge
Consultant-led collaboration is delivered through multidisciplinary teams and will soon be available via our eMDT platform.
Our unique partnership with the Penny Brohn UK charity supports patients to achieve clinically significant improvements in wellbeing. Trained and qualified therapists within our centres offer this service to all of our patients.
Our partnership with the world-leading expert, Professor Robert Newton, enables us to offer an evidence-based approach to exercise medicine. Exercise is effective in reducing the burden of several specific cancers and can demonstrate improvements in treatment tolerance, muscle mass, physical function, self-esteem, QoL and cancer-related fatigue.
Research and knowledge
Pathways are designed around evidence-based protocols, using clinical trials research and data insights. We run clinical trials and welcome approaches to our Trials Committee. We have an ongoing medical education programme, development workshops, leadership courses and consultant programmes.